Good Afternoon All,
I've done my research and won't stop.
A good number of months ago, approx. a year or so ago, I started reading up & started my investing in KNR. Part of my decision to buy in was BioCloud plus their other business verticals.
In all of this the success of any well run business is also thanks to the managememt, and their teams efforts.
The NRs, interviews and Qtrly results also provide the ongoing business execution results by Management and Teams that will determine the firm's future success.
Every month, I review investment opportunities and I still keep picking up more shares of KNR after my analysis. One reason why is simply sheer value at these $2.xx sp levels.
Concerning competition, the world is a very very big place open to more players than we can measure for countless products.
What matters is the product involved and how well it addresses the interests and concerns of end users.. With all the info provided by Kontrol to date on BioCloud, IMO, I believe they have a ' Gold Standard ' with BioCloud.
A ' hint ' of this ' Gold Standard ' are KNR's growing list of Blue Chips partnering with them for KNR's business vertical opportunties, and not just for BioCloud .
The KNR package of ' Safe Space Technology ' is ever growing, ever improving for the clients best interests.
In my ' books ', I also like to know some of the competition out there.
An interesting Cdn competitor is Poppy.com. Here is a snippet from their website:
A good introduction. I believe their price per box is approx >$15K.